↓ Skip to main content

Dove Medical Press

Article Metrics

Current management of parainfluenza pneumonitis in immunocompromised patients: a review

Overview of attention for article published in Infection and Drug Resistance, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
43 Mendeley
Title
Current management of parainfluenza pneumonitis in immunocompromised patients: a review
Published in
Infection and Drug Resistance, August 2012
DOI 10.2147/idr.s25874
Pubmed ID
Authors

Ann Falsey

Abstract

Parainfluenza viruses (PIV) are common respiratory viruses that belong to the Paramyxoviridae family. PIV infection can lead to a wide variety of clinical syndromes ranging from mild upper respiratory illness to severe pneumonia. Severe disease can be seen in elderly or chronically ill persons and may be fatal in persons with compromised immune systems, particularly children with severe combined immunodeficiency disease syndrome and hematopathic stem cell transplant recipients. At present, there are no licensed antiviral agents for the treatment of PIV infection. Aerosolized or systemic ribavirin in combination with intravenous gamma globulin has been reported in small, uncontrolled series and case reports of immunocompromised patients. A number of agents show antiviral activity in vitro and in animals, but none are currently approved for human use.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
United Kingdom 1 2%
Unknown 40 93%

Demographic breakdown

Readers by professional status Count As %
Other 6 14%
Student > Ph. D. Student 5 12%
Researcher 4 9%
Student > Doctoral Student 4 9%
Student > Bachelor 4 9%
Other 12 28%
Unknown 8 19%
Readers by discipline Count As %
Medicine and Dentistry 17 40%
Agricultural and Biological Sciences 6 14%
Biochemistry, Genetics and Molecular Biology 5 12%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Computer Science 2 5%
Other 4 9%
Unknown 7 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2012.
All research outputs
#2,972,138
of 4,506,762 outputs
Outputs from Infection and Drug Resistance
#47
of 71 outputs
Outputs of similar age
#47,514
of 76,515 outputs
Outputs of similar age from Infection and Drug Resistance
#5
of 5 outputs
Altmetric has tracked 4,506,762 research outputs across all sources so far. This one is in the 31st percentile – i.e., 31% of other outputs scored the same or lower than it.
So far Altmetric has tracked 71 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 76,515 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one.